EPS8 inhibition increases cisplatin sensitivity in lung cancer cells.
about
Identification of human leukemia antigen A*0201-restricted epitopes derived from epidermal growth factor pathway substrate number 8Identification of HLA‑A*1101‑restricted cytotoxic T lymphocyte epitopes derived from epidermal growth factor pathway substrate number 8.EPS8 regulates proliferation, apoptosis and chemosensitivity in BCR-ABL positive cells via the BCR-ABL/PI3K/AKT/mTOR pathway.Induction of Cbl-dependent epidermal growth factor receptor degradation in Ling Zhi-8 suppressed lung cancer.A synthetic cell-penetrating peptide derived from nuclear localization signal of EPS8 exerts anticancer activity against acute myeloid leukemia.
P2860
EPS8 inhibition increases cisplatin sensitivity in lung cancer cells.
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
EPS8 inhibition increases cisplatin sensitivity in lung cancer cells.
@ast
EPS8 inhibition increases cisplatin sensitivity in lung cancer cells.
@en
type
label
EPS8 inhibition increases cisplatin sensitivity in lung cancer cells.
@ast
EPS8 inhibition increases cisplatin sensitivity in lung cancer cells.
@en
prefLabel
EPS8 inhibition increases cisplatin sensitivity in lung cancer cells.
@ast
EPS8 inhibition increases cisplatin sensitivity in lung cancer cells.
@en
P2093
P2860
P1433
P1476
EPS8 inhibition increases cisplatin sensitivity in lung cancer cells.
@en
P2093
Amy L Stark
Lidija K Gorsic
M Eileen Dolan
Shan S Wong
P2860
P304
P356
10.1371/JOURNAL.PONE.0082220
P407
P577
2013-12-19T00:00:00Z